Compare AMETEK, Inc. (AME) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AMETEK, Inc. vs Twist Bioscience Corp — how do they compare? AMETEK, Inc. trades at $255.78 (market cap $58.76B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: AMETEK, Inc. is far larger — about 7.6× Twist Bioscience Corp's market cap, and AMETEK, Inc. pays a 0.53% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| AME | TWST | |
|---|---|---|
Market Cap | $58.76B | $7.72B |
Sector | Industrials | Health |
52-Week High | $256.30 | $124.88 |
52-Week Low | $179.28 | $24.16 |
Enterprise Value | $60.30B | $7.65B |
Dividend Yield | 0.53% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AMETEK, Inc.
Ametek is a diversified industrial conglomerate with over $6 billion in sales. The firm operates through an electronic instruments group and an electromechanical group. EIG designs and manufactures differentiated and advanced instruments for the process, aerospace, power, and industrial end markets. EMG is a focused, niche supplier of highly engineered automation solutions, thermal management systems, specialty metals, and electrical interconnects, among other products. About half of the firm's sales are made in the United States. The firm's asset-light strategy in place for nearly two decades emphasizes growth through acquisitions, new product development through research and development, driving operational efficiencies, and global and market expansion.
Read more on AME →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
